Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

GT Biopharma (GTBP) Revenue (2018 - 2021)

GT Biopharma (GTBP) has disclosed Revenue for 7 consecutive years, with -$22000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Revenue changed N/A to -$22000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$22000.0, a N/A change, with the full-year FY2025 number at -$127000.0, changed N/A from a year prior.
  • Revenue was -$22000.0 for Q4 2021 at GT Biopharma, down from $3.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.6 million in Q4 2019 to a low of -$1.1 million in Q3 2018.
  • A 3-year average of $499250.0 and a median of -$250500.0 in 2019 define the central range for Revenue.